Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53.

Journal of pharmacological and toxicological methods - 1 Jan 2000

Foroutan Behzad, Ruf Afruj Ali, Costall Brenda, Anderson Diana

Abstract excerpt

INTRODUCTION: P-Glycoprotein plays a major role in regulating the concentration of chemotherapeutic agents inside the cytoplasm of normal and cancerous cells. The present in vitro study has primarily focused on the evaluation of the chemosensitising drug model, verapamil, as a P-glycoprotein antagonist not only to overcome chemoresistance in non-Hodgkin's lymphoma (NHL) chemoresistant cells (p53(+) i.e....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caco-2 Cells
Share to Comet Assay
Share to Cyclophosphamide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doxorubicin

Share to Lymphoma, Non-Hodgkin

Share to Prednisone

Share to Verapamil

Share to Vincristine

Source

Identifiers

PMID: 16870476
DOI: 10.1016/j.vascn.2006.05.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53.PMID 16870476Read ↗

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy.Semantic proximity Read ↗

Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.Semantic proximity Read ↗

Establishment of in-vitro models of chemotherapy resistance.Semantic proximity Read ↗

[Multidrug resistance in chronic lymphocytic leukemia].Semantic proximity Read ↗

Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic ReticulumSemantic proximity Read ↗

Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.Semantic proximity Read ↗

Reduction of cellular cisplatin resistance by hyperthermia—a reviewSemantic proximity Read ↗

Apoptosis-resistant phenotype in HL-60-derived cells HCW-2 is related to changes in expression of stress-induced proteins that impact on redox status and mitochondrial metabolism.Semantic proximity Read ↗

Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico StudySemantic proximity Read ↗

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to OlaparibSemantic proximity Read ↗

Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.